Parkinson's disease is a neurodegenerative disease caused by the loss of dopamine-producing neurons in the brain. Its main motor symptoms include bradykinesia, rigidity, tremor, and postural instability. Non-motor symptoms like depression and cognitive impairment can also develop. Treatment focuses on restoring dopamine levels through levodopa administration, though psychotic symptoms may emerge as a complication requiring reduction of antiparkinsonian drugs, cholinesterase inhibitors, or atypical antipsychotics. Emerging therapies aim to improve drug delivery for Parkinson's disease.
Parkinson's disease is a neurodegenerative disease caused by the loss of dopamine-producing neurons in the brain. Its main motor symptoms include bradykinesia, rigidity, tremor, and postural instability. Non-motor symptoms like depression and cognitive impairment can also develop. Treatment focuses on restoring dopamine levels through levodopa administration, though psychotic symptoms may emerge as a complication requiring reduction of antiparkinsonian drugs, cholinesterase inhibitors, or atypical antipsychotics. Emerging therapies aim to improve drug delivery for Parkinson's disease.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as PPTX, PDF, TXT or read online from Scribd
Parkinson's disease is a neurodegenerative disease caused by the loss of dopamine-producing neurons in the brain. Its main motor symptoms include bradykinesia, rigidity, tremor, and postural instability. Non-motor symptoms like depression and cognitive impairment can also develop. Treatment focuses on restoring dopamine levels through levodopa administration, though psychotic symptoms may emerge as a complication requiring reduction of antiparkinsonian drugs, cholinesterase inhibitors, or atypical antipsychotics. Emerging therapies aim to improve drug delivery for Parkinson's disease.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as PPTX, PDF, TXT or read online from Scribd
Sachdev Vinay, Gnanendra Reddy and Mayuresh Puranik
Abstract Results The treatment includes restoration of Dopamine basically through Parkinson's disease (PD) is a chronic neurodegenerative adminsitration of Levodopa. The mechanism of action is shown in the disease, in which mainly dopaminergic neurons in the following figure. substantia nigra in the brain degenerate, leading to a depletion of dopamine (DA) in the striatum. The most important motor disturbances of the disease are bradykinesia (slowing down of movement), hypokinesia (poverty of movement), rigidity (muscle stiffness), tremor and postural instability. Besides these well-known motor symptoms, non-motor symptoms may develop, such as depression, cognitive impairment and psychosis. Psychotic symptoms constitute a relatively common but nevertheless serious complication, with visual hallucinations and paranoid delusions often being most prominent. These symptoms are important contributors to patient and caregiver distress and are often important risk factors for nursing home placement. Exogenous (related to therapeutic interventions) factors are of major importance but endogenous (related to the disease process itself ) factors might also contribute to the development of psychotic symptoms in PD. Therapeutic strategies comprise reduction of antiparkinsonian treatment, cholinesterase inhibitors and atypical antipsychotics. As psychotic symptoms in PD are often influenced by both endogenous and exogenous factors, a combination of strategies may be chosen.
Introduction
Discussion
Emerging Therapies for Parkinson’s Disease
The most common movement disorder affecting 1-2 % of the
general population over the age of 65 years.
The second most common neurodegenerative disorder after
Alzheimer´s disease (AD).
Symptoms include
Muscle rigidity, detectable as an increased resistance inpassive
limb movement
Bradykinesia Advances in Drug Delivery for Parkinson’s Disease Therapies
Suppression of voluntary movements (hypokinesis), due partlyto
an inherent inertia of the motor system, which means that motor activity is difficult to stop as well as to initiate.